Survival benefit of high dose therapy over sequential chemotherapy in poor risk aggressive non-Hodgkin's lymphoma. Final analysis of the prospective LNH87-2 protocol. A gela study.

被引：0
|
作者：
Haioun, C [1 ]
Lepage, E [1 ]
Gisselbrecht, C [1 ]
Salles, G [1 ]
Coiffier, B [1 ]
Brice, P [1 ]
Bosly, A [1 ]
Morel, P [1 ]
Nouvel, C [1 ]
Tilly, H [1 ]
Lederlin, P [1 ]
Sebban, C [1 ]
Briere, J [1 ]
Gaulard, P [1 ]
Reyes, F [1 ]
机构：
[1] Hop Henri Mondor, F-94010 Creteil, France
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2711
引用
收藏
页码：610A / 610A
页数：1
相关论文
共 50 条
  • [1] Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2
    Haioun, C
    Lepage, E
    Gisselbrecht, C
    Bastion, Y
    Coiffier, B
    Brice, P
    Bosly, A
    Dupriez, B
    Nouvel, C
    Tilly, H
    Lederlin, P
    Biron, P
    Briere, J
    Gaulard, P
    Reyes, F
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1131 - 1137
  • [2] Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma:: Final analysis of the prospective LNH87-2 protocol -: A Groupe d'Etude des Lymphomes de l'Adulte Study
    Haioun, C
    Lepage, E
    Gisselbrecht, C
    Salles, G
    Coiffier, B
    Brice, P
    Bosly, A
    Morel, P
    Nouvel, C
    Tilly, H
    Lederlin, P
    Sebban, C
    Brière, J
    Gaulard, P
    Reyes, F
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) : 3025 - 3030
  • [3] Autologous transplantation versus conventional salvage therapy in aggressive non-Hodgkin's lymphoma (NHL) partially responding to first line chemotherapy. A study of 94 patients enrolled in the LNH87-2 protocol.
    Haioun, C
    Lepage, E
    Gisselbrecht, C
    Coiffier, B
    Doyen, C
    Morel, P
    Artal, M
    Tilly, H
    Deconinck, E
    Gaulard, P
    Reyes, F
    BONE MARROW TRANSPLANTATION, 1998, 21 : S173 - S173
  • [4] Alternance of chemotherapy does not improve results in aggressive non-Hodgkin's lymphoma: A prospective randomized study on 884 patients LNH87 protocol group 3: A gela study
    Bosly, A
    Lepage, E
    Coiffier, B
    Dupriez, B
    Herbrecht, R
    Fillet, G
    Divine, M
    Nouvel, C
    Tilly, H
    Bordessoule, D
    Gaulard, P
    Gisselbrecht, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 546 - 546
  • [5] High dose therapy may have no survival benefit over CHOEP primary chemotherapy for people with aggressive non-Hodgkin's lymphoma
    Glasmacher, A
    CANCER TREATMENT REVIEWS, 2003, 29 (02) : 139 - 142
  • [6] Autologous transplantation versus conventional salvage therapy in aggressive non Hodgkin's lymphoma (NHL) partially responding to first line chemotherapy. A study of 96 patients enrolled in the LNH87-2 protocol.
    Haioun, C
    Lepage, E
    Gisselbrecht, C
    Bastion, Y
    Doyen, C
    Plantier, I
    Schlaifer, D
    Tilly, H
    Deconinck, E
    Bordessoule, D
    Gaulard, P
    Reyes, F
    BLOOD, 1995, 86 (10) : 833 - 833
  • [7] Autologous bone marrow transplantation (ABMT) versus sequential chemotherapy for aggressive non Hodgkin's lymphoma (NHL) in first complete remission (CR): A study of 541 patients (LNH87-2 protocol)
    Haioun, G
    Lepage, E
    Gisselbrecht, C
    Coiffier, B
    Bosly, A
    Dupriez, B
    Nouvel, C
    Tilly, H
    Lederlin, P
    Biron, P
    Briere, J
    Gaulard, P
    Reyes, F
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 545 - 545
  • [8] Autologous bone marrow transplantation (ABMT) versus sequential chemotherapy for aggressive non Hodgkin's lymphoma (NHL) in first complete remission (CR): A study of 542 patients (LNH87-2 protocol).
    Haioun, C
    Lepage, E
    Gisselbrecht, C
    Coiffier, B
    Bosly, A
    Dupriez, B
    Nouvel, C
    Tilly, H
    Lederlin, P
    Biron, P
    Briere, J
    Gaulard, P
    Reves, F
    BLOOD, 1995, 86 (10) : 1816 - 1816
  • [9] Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Concerns about omissions in the data presented
    Kennedy, RD
    Cuthbert, RG
    Kettle, PJ
    Morris, TCM
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) : 1884 - 1884
  • [10] Cologne high-dose sequential chemotherapy in relapsed and refractory aggressive Non-Hodgkin's lymphoma - Results of multicenter phase II study.
    Josting, A
    Sieniawski, M
    Staak, O
    Glossmann, JP
    Diehl, V
    Engert, A
    BLOOD, 2003, 102 (11) : 405A - 405A
12345